• MK-4827 (Niraparib) for BRCA-Mutant Cancer Research Workflow

  2026-05-02

  MK-4827 (Niraparib) empowers precise DNA damage repair inhibition and synthetic lethality studies in BRCA-1/2 mutant cancer models. This comprehensive guide details optimized experimental workflows, troubleshooting strategies, and translational insights, enabling researchers to maximize the impact of this selective PARP-1/-2 inhibitor.

• CLCC1 Identified as Key Host Factor in Herpesvirus Nuclear E

  2026-05-01

  A recent study uncovers the host chloride channel CLCC1 as essential for the membrane fusion step of herpesvirus nuclear egress, using a genome-wide CRISPR screen in HSV-1 infection models. This finding advances understanding of virus-host interactions and may inform future antiviral strategies targeting egress mechanisms.

• ABT-263 (Navitoclax): Redefining Apoptosis Assays via Bcl-2

  2026-04-30

  Explore how ABT-263 (Navitoclax) transforms apoptosis assay design and cancer biology research. This in-depth analysis reveals unique mechanistic insights and practical assay guidance unavailable in prior resources.

• FLAG tag Peptide: Optimizing Recombinant Protein Detection

  2026-04-30

  The FLAG tag Peptide (DYKDDDDK) offers unmatched precision for recombinant protein purification and detection workflows. Integrating new structural insights and high-purity synthesis, this guide details advanced applications, protocol best practices, and troubleshooting strategies to empower reproducible results.

• c-Myc Tag Peptide: Mechanistic Precision for Translational S

  2026-04-29

  This thought-leadership article explores the mechanistic and strategic utility of the c-Myc tag peptide in immunoassays and transcription factor research, focusing on its role in displacement of c-Myc-tagged fusion proteins and anti-c-Myc antibody binding inhibition. We examine how this synthetic tool, available from APExBIO, bridges foundational mechanistic understanding to high-impact translational workflows, and we contextualize these advances with recent literature—highlighting new intersections between transcription factor regulation, autophagy, and immune signaling.

• Plk1 Regulation of p31comet in Mitotic Checkpoint Disassembl

  2026-04-29

  This study elucidates how Polo-like kinase 1 (Plk1) directly regulates the activity of p31comet, a critical player in mitotic checkpoint complex (MCC) disassembly. By mapping a specific phosphorylation event, the findings clarify a key mechanism controlling chromosome segregation fidelity and suggest new angles for targeted cell cycle research.

• NSC23766 trihydrochloride: Targeting Rac1 Beyond Cancer Rese

  2026-04-28

  Explore how NSC-23766, a selective Rac GTPase inhibitor, unlocks new frontiers in metabolic and cancer biology by modulating Rac1 signaling. This in-depth analysis integrates mechanistic insights and practical assay guidance for advanced research.

• SUMOylation of Human ANP32A/B Enables Avian Influenza Adapta

  2026-04-28

  The referenced study reveals that human ANP32A/B proteins become SUMOylated and are exploited by avian influenza virus (AIV) NS2 protein to overcome species-specific replication barriers. These mechanistic insights clarify how AIV adapts to mammalian hosts and highlight SUMO-mediated host-pathogen interactions as key determinants of cross-species transmission.

• ω-Agatoxin IVA TFA (SKU C8722): Reliable P/Q-Type Channel Bl

  2026-04-27

  This article demonstrates how ω-Agatoxin IVA TFA (SKU C8722) enables reproducible, high-sensitivity interrogation of P/Q-type calcium channels in neuronal assays. Through scenario-driven Q&A, we address protocol optimization, selectivity, and vendor benchmarking, guiding researchers to robust data and workflow confidence when using ω-Agatoxin IVA TFA from APExBIO.

• Anti Reverse Cap Analog: Enhancing Synthetic mRNA Translatio

  2026-04-27

  Harness the translational power of Anti Reverse Cap Analog (ARCA), 3´-O-Me-m7G(5')ppp(5')G, to deliver high-efficiency, orientation-specific capping for mRNA workflows. Unlock next-generation applications in mRNA therapeutics, gene editing, and advanced metabolic research with precision and reproducibility.

• TAI-1: Precision Hec1 Inhibition for Genome Stability Resear

  2026-04-26

  Explore how TAI-1, a first-in-class Hec1 inhibitor, enables highly selective disruption of mitotic regulation and genome integrity in cancer. This article uniquely bridges mechanistic insights and protocol guidance for advanced genomic stability assays and translational oncology.

• PDI Inhibition Enhances Panobinostat Efficacy in Multiple My

  2026-04-25

  This study introduces the combination of the PDI inhibitor LTI6426 with panobinostat as a strategy to enhance anti-myeloma efficacy at lower, less toxic doses. The work identifies key ER stress pathway biomarkers and supports rational design of multi-agent regimens targeting proteostasis in multiple myeloma.

• Dabigatran (Pradaxa): Applied Workflows for Thrombin Inhibit

  2026-04-24

  Dabigatran (Pradaxa) empowers researchers with high-reproducibility thrombin inhibition for functional coagulation assays and translational stroke prevention models. This article breaks down experimental setup, troubleshooting, and optimization for bench scientists, leveraging APExBIO’s product consistency and the latest literature-backed insights.

• Dextrose (D-glucose): Powering Advanced Glucose Metabolism R

  2026-04-24

  Dextrose (D-glucose) from APExBIO offers unmatched solubility and purity, enabling reproducible, high-resolution insights in glucose metabolism, immunometabolism, and tumor microenvironment studies. This guide translates cutting-edge research into stepwise protocols, troubleshooting tips, and practical workflow enhancements.

• Topotecan as a Topoisomerase I Inhibitor: Clinical and Mecha

  2026-04-23

  This review details Topotecan’s emergence as a potent, water-soluble topoisomerase I inhibitor for cancer therapy. It highlights the unique mechanism, key pharmacologic properties, and significant clinical activity in ovarian and small cell lung cancers, providing researchers with critical context for both experimental design and translational applications.

16730 records 1/1116 page Next 12345 下5页 Last page